Revista Peruana de Medicina Experimental y Salud Pública
Print version ISSN 1726-4634
SAAVEDRA, Herbert et al. Neurocysticercosis diagnosis and management in Peru. Rev Peru Med Exp Salud Publica [online]. 2010, vol.27, n.4, pp. 586-591. ISSN 1726-4634. http://dx.doi.org/10.1590/S1726-46342010000400015.
Neurocysticercosis (NCC) is the most common parasitic disease of the central nervous system and is caused by larvae of the tapeworn Taenia solium. NCC is endemic in almost all developing countries. It presents as intraparenchymal forms associated with seizures or as extraparenchymal forms associated with intracranial hypertension. The clinical and epidemiological suspicion are important but the diagnosis is made primarily by images and confirmed by serology. Computed tomography (CT) and magnetic resonance imaging tests are used. Inmunodiagnosis by Western Blot, which is currently perform in the Instituto Nacional de Ciencias Neurológicas in serum and cerebrospinal fluid serves as confirmatory test. Treatment involves symptomatic measures (control of seizures or intracranial hypertension) and anticysticercal medications (albendazole and praziquantel). Anticysticercal treatment should be used under hospital conditions because of secondary effects.
Keywords : Neurocysticercosis; Albendazole; Praziquantel; Taenia solium; Peru.